Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin vs glimepiride for nocturnal hypoglycemia and arrhythmias in type 2 diabetes on metformin
2014-003792-34Phase 4Terminated
- Sponsor
- GWT-TUD
- Start
- Nov 2014
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Sitagliptin + metformin with Glimepiride + metformin (2 arms). Primary endpoint: Hypoglycemic episodes and time of episodes. Started Nov 2014; status: terminated.
02
Drugs
sitagliptinglimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2014-003792-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003792-34.